Drug Shortage Report for CUPRIMINE
| Report ID | 2263 |
| Drug Identification Number | 00016055 |
| Brand name | CUPRIMINE |
| Common or Proper name | D-PENICILLAMINE capsule |
| Company Name | BAUSCH HEALTH, CANADA INC. |
| Market Status | MARKETED |
| Active Ingredient(s) | D-PENICILLAMINE |
| Strength(s) | 250mg |
| Dosage form(s) | Capsule |
| Route of administration | Oral |
| Packaging size | 100 |
| ATC code | M01CC |
| ATC description | SPECIFIC ANTIRHEUMATIC AGENTS |
| Reason for shortage | Disruption of the manufacture of the drug. |
| Anticipated start date | 2017-03-14 |
| Actual start date | |
| Estimated end date | 2017-04-17 |
| Actual end date | 2017-08-16 |
| Shortage status | Resolved |
| Updated date | 2017-08-17 |
| Company comments | |
| Health Canada comments | |
| Tier 3 Status | No |
| Contact Address | 2150 BOUL. ST-ELZEAR OUEST LAVAL, QUEBEC CANADA H7L 4A8 |
| Company contact information |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
| Version Number | Date Updated | Language | |
|---|---|---|---|
| v9 | 2017-08-17 | French | Compare |
| v8 | 2017-08-17 | English | Compare |
| v7 | 2017-04-18 | French | Compare |
| v6 | 2017-04-18 | English | Compare |
| v5 | 2017-04-06 | French | Compare |
| v4 | 2017-04-06 | English | Compare |
| v3 | 2017-03-15 | English | Compare |
| v2 | 2017-03-14 | French | Compare |
| v1 | 2017-03-14 | English | Compare |
Showing 1 to 9 of 9